29,176 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

GSK Competitors or Alternatives

GSK's top competitors include AstraZeneca, Pfizer and Novartis.

Unlock 17 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

GSK's company profile

Dame Emma Walmsley

CEO

67/100
70,200
$2.3B
$41B
  • $2.3B
    $41B
  • 70,200
    $2.3B
  • $41B
  • 67/100
  • 70,200
  • $2.3B
  • $41B
View ProfileView
1
GSK's Competitor - AstraZeneca logo

Pascal Soriot

CEO

72/100
89,900
$100M
$51.2B
  • $100M
    $51.2B
  • 89,900
    $100M
  • $51.2B
  • 72/100
  • 89,900
  • $100M
  • $51.2B
View ProfileView
2
GSK's Competitor - Pfizer logo

Albert Bourla

Chairman & CEO

69/100
83,000
$1B
$63.6B
  • $1B
    $63.6B
  • 83,000
    $1B
  • $63.6B
  • 69/100
  • 83,000
  • $1B
  • $63.6B
View ProfileView
3
GSK's Competitor - Novartis logo

Vasant Narasimhan

CEO

88/100
75,883
- -
$50.3B
  • - -
    $50.3B
  • 75,883
    - -
  • $50.3B
  • 88/100
  • 75,883
  • - -
  • $50.3B
View ProfileView
4
GSK's Competitor - Bristol-Myers Squibb logo

Christopher Boerner

CEO

46/100
34,300
$23.5B
$47.6B
  • $23.5B
    $47.6B
  • 34,300
    $23.5B
  • $47.6B
  • 46/100
  • 34,300
  • $23.5B
  • $47.6B
View ProfileView
5
GSK's Competitor - Johnson & Johnson logo

Joaquin Duato

Chairman & CEO

62/100
152,700
- -
$89.3B
  • - -
    $89.3B
  • 152,700
    - -
  • $89.3B
  • 62/100
  • 152,700
  • - -
  • $89.3B
View ProfileView
GSK's top 20 competitors are AstraZeneca, Pfizer, Novartis, Abbott, Bristol-Myers Squibb, Johnson & Johnson, Merck, Roche, Lilly, Cipla, TEVA, Gilead, Genentech, Sanofi Pasteur, Amgen, AbbVie, Sanofi, Bayer , Biogen and Boehringer Ingelheim. Together they have raised over 74.2B between their estimated 1.2M employees. GSK has 70,200 employees and is ranked 9th among it's top 10 competitors. The top 10 competitors average 60,794.

GSK VS AstraZeneca

AstraZeneca is perceived as one of GSK's biggest rivals. AstraZeneca was founded in 1999 in Cambridge, England. AstraZeneca is in the Pharmaceuticals field. AstraZeneca generates $10.2B more revenue than GSK.

GSK VS Pfizer

Pfizer is GSK's #2 rival. Pfizer is a Public company that was founded in 1849 in New York, New York. Pfizer competes in the Pharmaceuticals field. Compared to GSK, Pfizer has 12,800 more employees.

GSK VS Novartis

Novartis is one of GSK's top competitors. Novartis's headquarters is in Basel, Basel-City, and was founded in 1996. Like GSK, Novartis also operates in the Pharmaceuticals industry. Novartis generates 122% of GSK's revenue.

Looking for similar companies to GSK?

Similar Companies

Biotechnology companies with revenue in $10-50B range

See 11 companies 
Pharmaceuticals companies with employees in 50-100K range

See 15 companies 
Pharmaceuticals companies with revenue in $10-50B range

See 32 companies 
Pharmaceuticals & Biotechnology companies with employees in 50-100K range

See 20 companies 
Pharmaceuticals & Biotechnology companies with revenue in $10-50B range

See 40 companies 
Companies in London with employees in 50-100K range

See 44 companies 
Companies in London with revenue in $10-50B range

See 57 companies 
Companies in England with employees in 50-100K range

See 60 companies 
Companies in United Kingdom with employees in 50-100K range

See 64 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for GSK and GSK's Competitors

April 30, 2025Marketscreener
LONDON (AP) - LONDON (AP) - GSK plc (GSK) on Wednesday reported first-quarter earnings of $2.04 billion . The London -based company said it had profit ...
April 30, 2025Medthority
The trial met its primary endpoint of event-free survival (EFS) by investigator assessment, demonstrating a clinically meaningful and statistically sig...
April 29, 2025Marketscreener
CAMBRIDGE , Britain (AP) - CAMBRIDGE , Britain (AP) - Astrazeneca PLC (AZN) on Tuesday reported first-quarter profit of $2.92 billion . On a per-share ...
April 30, 2025Medthority
The collaboration aims to improve workflow efficiency for providers through Epic's Aura software, which brings health systems together with diagnostics...
April 30, 2025Endpoints News
Novartis plans to acquire Regulus Therapeutics for $7.00 per share in cash, or $800 million, the microRNA specialist said Wednesday. This is more than ...
April 30, 2025Pharmabiz
Roche announced that the US Food and Drug Administration (FDA) granted Breakthrough Device Designation for the VENTANA TROP2 (EPR20043) RxDx Device....
April 30, 2025FinanzNachrichten
NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) announced the FDA has approved IMAAVY, a human FcRn-blocking monoclonal antibody, for the treatment o...
April 29, 2025NewYork Post
The new facility will produce biologic drugs and Keytruda, becoming Merck's first in-house US site to make the blockbuster cancer treatment, the compan...
April 30, 2025Nasdaq
Eli Lilly (NYSE:LLY) is scheduled to release its earnings report on Thursday, May 1, 2025. For event-driven traders, historical stock performance follo...
April 30, 2025Nasdaq
Bristol Myers Squibb (NYSE:BMY) recently reported its first-quarter results, with adjusted earnings of $1.80 per share on revenue of $11.2 billion. Thi...

Frequently Asked Questions about GSK

  1. Who are GSK's top competitors?

    GSK's top 3 competitors are AstraZeneca, Pfizer, Novartis.

  2. Who is similar to GSK?

    AstraZeneca is the most similar to GSK. Pfizer and Novartis are also similar to GSK.

  1. Are GSK and AstraZeneca competitors?

    Yes, AstraZeneca is one of GSK’s top competitors.